MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-09-30, RAPT made $21,246,000 in revenue. -$17,496,000 in net income. Net profit margin of -82.35%.

Income Overview

Revenue
$21,246,000
Net Income
-$17,496,000
Net Profit Margin
-82.35%
EPS
-$0.65
Unit: Dollar
Revenue Breakdown
    • Research and development
    • General and administrative
    • Other income, net
    • Unrealized gain on marketable se...

Unit: Dollar
Income Statement
2025-09-30
2025-06-30
2025-03-31
2024-12-31
Research and development
12,034,000 12,340,000 12,042,000 31,292,333.333
General and administrative
7,337,000 7,195,000 7,223,000 7,478,666.667
Total operating expenses
19,371,000 19,535,000 19,265,000 38,771,000
Loss from operations
-19,371,000 -19,535,000 -19,265,000 -38,771,000
Other income, net
1,791,000 1,892,000 2,100,000 1,626,666.667
Net loss
-17,580,000 -17,643,000 -17,165,000 -37,144,333.333
Unrealized gain on marketable securities
84,000 -19,000 -15,000 -69,000
Total comprehensive loss
-17,496,000 -17,662,000 -17,180,000 -37,213,333.333
Net loss per share, basic
-0.65 -0.65 -0.08 -0.907
Net loss per share, diluted
-0.65 -0.65 -0.08 -0.907
Weighted-average shares used to compute net loss per share, basic
26,963,107 26,949,752 215,410,253 619,222.333
Weighted-average shares used to compute net loss per share, diluted
26,963,107 26,949,752 215,410,253 619,222.333
Unit: Dollar

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Total comprehensiveloss-$17,496,000 Unrealized gain onmarketable securities$84,000 Net loss-$17,580,000 Other income, net$1,791,000 Loss from operations-$19,371,000 Total operatingexpenses$19,371,000 General andadministrative$7,337,000 Research and development$12,034,000

RAPT Therapeutics, Inc. (RAPT)

RAPT Therapeutics, Inc. (RAPT)